Clinical Trial Update: Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating avatrombopag for chronic immune thrombocytopenia in Japanese adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Sobi, Inc. | Conditions: Immune Thrombocytopenia | Phase 3 | Status: COMPLETED | Results posted: 2025-02-11